MERCK & CO., INC. (MRK)
Clinical trial NCT06575959: enrollment: not set → 20 participants.
ASTRAZENECA PLC (AZN)
Clinical trial NCT06512883 updates: 1. completion date: 2028-04-03 → 2029-05-14 2. enrollment: not set → 14 participants
ABBVIE INC. (ABBV)
Clinical trial NCT04928846: enrollment: not set → 698 participants.
STRYKER CORP (SYK)
Clinical trial NCT07371091 updates: 1. start date: 2026-02-01 → 2026-07-01 2. enrollment: not set → 110 participants
RAPPORT THERAPEUTICS, INC. (RAPP)
Clinical trial NCT07563881: enrollment: not set → 333 participants.
ELI LILLY & CO (LLY)
Clinical trial NCT04956640 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 540 participants
REGENERON PHARMACEUTICALS, INC. (REGN)
Clinical trial NCT07318597 updates: 1. start date: 2026-04-30 → 2026-05-06 2. completion date: 2028-09-27 → 2028-09-17 3. primary completion date: 2028-03-08 → 2028-02-27 4. enrollment: not set → 99 participants
INSULET CORPORATION
Clinical trial NCT07039942 updates: 1. completion date: 2027-05-01 → 2027-10-01 2. primary completion date: 2027-05-01 → 2027-10-01 3. enrollment: not set → 304 participants
DR REDDYS LABORATORIES LTD (RDY)
Clinical trial NCT05200559 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-12-01 → 2030-12-31 3. primary completion date: 2025-12-01 → 2030-05-31 4. enrollment: not set → 25 participants
NOVARTIS AG (NVSEF)
Clinical trial NCT06335979 updates: 1. completion date: 2027-07-09 → 2027-11-17 2. primary completion date: 2027-07-09 → 2027-11-17 3. enrollment: not set → 54 participants